VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,147,000 | -80.8% | 81,634 | -26.0% | 0.92% | -81.7% |
| Q4 2015 | $11,208,000 | -16.5% | 110,258 | +46.6% | 5.05% | -20.5% |
| Q3 2015 | $13,418,000 | -9.5% | 75,223 | +12.6% | 6.35% | -5.5% |
| Q2 2015 | $14,834,000 | +24.6% | 66,777 | +11.4% | 6.72% | +12.0% |
| Q1 2015 | $11,902,000 | +38.9% | 59,922 | +0.1% | 6.00% | +30.0% |
| Q4 2014 | $8,566,000 | +9.9% | 59,857 | +0.8% | 4.62% | +4.8% |
| Q3 2014 | $7,791,000 | +4.6% | 59,384 | +0.6% | 4.41% | +1.3% |
| Q2 2014 | $7,445,000 | +0.4% | 59,031 | +5.0% | 4.35% | -6.9% |
| Q1 2014 | $7,412,000 | +12.2% | 56,224 | -0.1% | 4.67% | +9.5% |
| Q4 2013 | $6,609,000 | – | 56,298 | – | 4.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |